semaglutide for obesity Mechanism of management of obesity, NASH, and Two-year effects of semaglutide in

Incretin mimetics and acute pancreatitis: enemy or innocent bystander

This structured approach allows personalized titration rather than preset escalation, improving tolerability and outcomes according to compounding pharmacy outcome data

So many people are reporting significant weight loss with Wegovy or Mounjaro

Oral formulations may expand access to treatment, particularly for those reluctant to use injectable medications

Yes, alcohol can make nausea worse

RESULTS A total of 22 691 922 patients 45 years of age with overweight or obesity and ASCVD were identified with 14 483 receiving semaglutide and 10 642 receiving tirzepatide and fulfilling the remaining inclusion criteria (Figure 1)